Does LERCANIDIPINE Cause Hyponatraemia? 122 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Hyponatraemia have been filed in association with LERCANIDIPINE. This represents 3.2% of all adverse event reports for LERCANIDIPINE.
122
Reports of Hyponatraemia with LERCANIDIPINE
3.2%
of all LERCANIDIPINE reports
1
Deaths
113
Hospitalizations
How Dangerous Is Hyponatraemia From LERCANIDIPINE?
Of the 122 reports, 1 (0.8%) resulted in death, 113 (92.6%) required hospitalization, and 20 (16.4%) were considered life-threatening.
Is Hyponatraemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LERCANIDIPINE. However, 122 reports have been filed with the FAERS database.
What Other Side Effects Does LERCANIDIPINE Cause?
Acute kidney injury (424)
Hypotension (401)
Fall (323)
Hypertension (197)
Hyperkalaemia (176)
Drug ineffective (149)
Diarrhoea (122)
Renal impairment (120)
Oedema peripheral (114)
Syncope (114)
What Other Drugs Cause Hyponatraemia?
FUROSEMIDE (3,127)
HYDROCHLOROTHIAZIDE (2,138)
OMEPRAZOLE (1,635)
LANSOPRAZOLE (1,416)
SERTRALINE (1,332)
RAMIPRIL (1,178)
SPIRONOLACTONE (1,166)
PANTOPRAZOLE (1,134)
INDAPAMIDE (976)
AMLODIPINE (879)
Which LERCANIDIPINE Alternatives Have Lower Hyponatraemia Risk?
LERCANIDIPINE vs LETAIRIS
LERCANIDIPINE vs LETERMOVIR
LERCANIDIPINE vs LETROZOLE
LERCANIDIPINE vs LETROZOLE\RIBOCICLIB
LERCANIDIPINE vs LEUCOVORIN